The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Docetaxel Winthrop

20 milligram(s)/millilitre Concentrate for solution for infusion

Zentiva k.s.EU/1/07/384/003

Main Information

Trade NameDocetaxel Winthrop
Active SubstancesDocetaxel trihydrate
Strength20 milligram(s)/millilitre
Dosage FormConcentrate for solution for infusion
Licence HolderZentiva k.s.
Licence NumberEU/1/07/384/003

Group Information

ATC CodeL01CD Taxanes
L01CD02 docetaxel

Status

Authorised/WithdrawnAuthorised
Licence Issued30/11/2009
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2).
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website
« Back